What would the experts do? Genetic testing, surveillance, and risk-reduction preferences for BRCA and Lynch syndrome

被引:0
|
作者
Bonadies, Danielle C.
Matloff, Ellen T.
Brierley, Karina L.
Moyer, Anne
机构
[1] Yale Univ, New Haven, CT USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e12542
引用
收藏
页数:1
相关论文
共 39 条
  • [1] Follow-up recommendations and risk-reduction initiatives for Lynch syndrome
    Guillen-Ponce, Carmen
    Molina-Garrido, Maria-Jose
    Carrato, Alfredo
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1359 - 1367
  • [2] What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients
    Tiernan, Gabriella
    Freeman, Victoria
    Morrow, April
    Hogden, Emily
    Canfell, Karen
    Kang, Yoon-Jung
    Taylor, Natalie
    [J]. PSYCHO-ONCOLOGY, 2022, 31 (04) : 587 - 596
  • [3] Lynch Syndrome Expert Opinion Questionnaire - What Would You Do?
    Schneider, R.
    Schneider, C.
    Lindor, N.
    Macrae, E.
    Berks, T.
    Spigetman, A.
    Moeslein, G.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 75 - 75
  • [4] Does genetic counseling for women at high risk of harboring a deleterious BRCA mutation alter risk-reduction strategies and cancer surveillance behaviors?
    Henretta, M.
    Askew, A.
    Smolkin, M.
    Guffey, E.
    Modesitt, S.
    Cohn, W.
    Ropka, M.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S59 - S59
  • [5] Risk Assessment, Genetic Testing, and Management of Lynch Syndrome
    Grover, Shilpa
    Syngal, Sapna
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (01): : 98 - 105
  • [6] Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
    Kuppermann, Miriam
    Wang, Grace
    Wong, Shirley
    Blanco, Amie
    Conrad, Peggy
    Nakagawa, Sanae
    Terdiman, Jonathan
    Ladabaum, Uri
    [J]. CANCER, 2013, 119 (01) : 215 - 225
  • [7] Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients
    Hueneburg, Robert
    Aretz, Stefan
    Buettner, Reinhard
    Daum, Severin
    Engel, Christoph
    Fechner, Guido
    Habermann, Jens K.
    Heling, Dominik
    Hoffmann, Katrin
    Holinski-Feder, Elke
    Kloor, Matthias
    von Knebel-Doeberitz, Magnus
    Loeffler, Markus
    Moeslein, Gabriela
    Perne, Claudia
    Redler, Silke
    Riess, Olaf
    Schmiegel, Wolff
    Seufferlein, Thomas
    Siebers-Renelt, Ulrike
    Steinke-Lange, Verena
    Tecklenburg, Johanna
    Vangala, Deepak
    Vilz, Tim
    Weitz, Juergen
    Wiedenmann, Bertram
    Strassburg, Christian P.
    Nattermann, Jacob
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (11): : 1309 - 1320
  • [8] Surgical risk-reduction in carriers of BRCA mutations:: Where do we go from here?
    Kauff, ND
    Barakata, RR
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 277 - 279
  • [9] Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond
    Hall, M. J.
    Obeid, E. I.
    Schwartz, S. C.
    Mantia-Smaldone, G.
    Forman, A. D.
    Daly, M. B.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 565 - 574
  • [10] Optimizing prenatal genetic testing strategies: What you would do matters
    Kuppermann, Miriam
    Norton, Mary E.
    Nakagawa, Sanae
    O'Leary, Allison
    Thao, Kao
    Cortez, Abby
    Nseyo, Ono
    Kaimal, Anjali J.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S403 - S403